Anti-Oxidant Treatment of Alzheimer's Disease
Alzheimer's DiseaseThe purpose of this study is to examine the safety and effectiveness of two anti-oxidant treatment regimens in patients with mild to moderate Alzheimer's disease. The anti-oxidant treatments include vitamin E + C + alpha-lipoic acid, and Coenzyme Q (CoQ).
ALADDIN Study: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation
Alzheimer DiseaseALADDIN is a research study to investigate the safety and effectiveness of leuprolide (a hormone drug) to improve the cognitive function and slow the progression of Alzheimer's disease (AD). In women leuprolide is commonly used to treat hormone related conditions such as endometriosis and uterine fibroids. The study will include treatment of women 65 years and older with mild to moderate Alzheimer's disease who reside in the community.
Side Effects of Newer Antipsychotics in Older Adults
SchizophreniaAlzheimer's Disease1 moreThis study will compare four atypical antipsychotic medications in terms of the risk of specific side effects each of them presents in middle-aged and elderly individuals.
A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment...
DementiaAlzheimer DiseaseThe purpose of this study is to evaluate the efficacy and safety of galantamine treatment in patients with mild cognitive impairment.
Adding Atomoxetine To Standard Medication Treatment In Patients With Alzheimer's Disease
Alzheimer DiseaseThis study will compare atomoxetine to placebo when taken with current standard Alzheimer's Disease medications. The treatment will take approximately 6 months and it is hypothesized atomoxetine will significantly improve cognitive performance as compared to placebo.
Study Evaluating SRA-333 in Mild to Moderate Alzheimer's Disease (AD)
Alzheimer's DiseaseTo determine the safety and tolerability of multiple ascending fixed oral doses of SRA-333 in subjects with mild to moderate Alzheimer's disease.
Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the...
Alzheimer DiseaseThe purpose of this study is to learn if aripiprazole is safe and effective in the treatment of psychosis associated with dementia of the Alzheimer's type.
Gene Therapy for Alzheimer's Disease Clinical Trial
Alzheimer DiseaseThis Phase I clinical trial is the first step in testing gene therapy. This study is called a "Safety/Toxicity" study by the Food and Drug Administration, and primarily aims to determine whether the experimental protocol is safe for humans. It will determine whether the study procedure causes side effects in humans, and may also give us a preliminary sense of whether this will be effective in combating Alzheimer's disease in humans.
Treatment of Behavioral Symptoms in Alzheimer's Disease
Alzheimer's DiseasePsychosis1 moreThe optimal strategy for the treatment of behavioral complications in patients with probable Alzheimer's disease (AD) remains unclear. The objective of this study is to evaluate the risk of relapse following discontinuation of haloperidol in patients with Alzheimer's disease (AD) with psychosis or agitation who respond to it. In Phase A of this study, AD outpatients with behavioral complications receive 20 weeks of open haloperidol treatment with an oral dose of 1-5 mg daily, titrated individually to achieve the optimal trade-off between efficacy and side effects. Responders to Phase A participate in Phase B, a 24-week continuation trial in which patients are randomized to continuation haloperidol or placebo. The primary outcome is the time to relapse of psychosis or behavioral disturbance.
Effectiveness of A Nutritional Brain Metabolic Enhancer for Alzheimer Disease
Alzheimer DiseaseThe purpose of this study is to evaluate the effectiveness of a nutritional supplement that has been developed to improve the brain function of a patient with Alzheimer's disease.